Presenting Symptoms, Treatment Delay and Survival in Bladder Cancer
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 17 (2) , 163-167
- https://doi.org/10.3109/00365598309180162
Abstract
In 212 consecutive patients with bladder tumour, relationships between symptoms, demographic factors, delay before treatment and survival rate were investigated. The presenting symptom was haematuria in 79% of the patients. The interval from onset of symptoms until treatment averaged 28 weeks (median = 15 weeks). The general practitioner delay comprised half of the total delay. Patients with cystitis as the presenting symptom and women with haematuria had the longest doctor delay. The length of delay did not influence the crude survival rate in patients with tumours in the two highest TNM stages. In T1 and T2 tumours, shorter delay tended to give a better survival rate.Keywords
This publication has 7 references indexed in Scilit:
- An epidemiological case-control study of bladder cancer in males from a predominantly rural districtEuropean Journal of Cancer and Clinical Oncology, 1982
- Neuromuscular junction macromolecules in the pathogenesis of amyotrophic lateral sclerosisMedical Hypotheses, 1980
- A haematuria diagnostic service.BMJ, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- CANCER OF THE BLADDER PRESENTING AS “CYSTITIS” OR “PROSTATISM”The Medical Journal of Australia, 1969
- DELAY IN TREATING BLADDER TUMOURSThe Lancet, 1965